Press Releases ICON Public Limited Company

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-28 pm EDT			5-day change	1st Jan Change
321.1 ^USD	+0.11%		+1.00%	+13.42%

May. 16	Diamyd Medical AB Appoints ICON plc to Conduct Interim Analysis for the Phase 3 Trial	CI
Apr. 30	ICON Prices $2 Billion Debt Offering	MT

ICON plc to hold Investor Day Meeting on May 30, 2024	May. 20	BU
ICON releases its ICON Cares 2023 Report	May. 09	BU
ICON Public : Underwriting Agreement - Form 6-K	May. 08	PU
ICON Announces Pricing of USD 2 Billion Notes	Apr. 30	BU
Icon PLC: Q1 Earnings Snapshot	Apr. 24	AQ
ICON Reports First Quarter 2024 Results	Apr. 24	BU
ICON Announces CFO Transition	Apr. 03	BU
ICON plc Schedules First Quarter 2024 Earnings Conference Call	Mar. 25	BU
ICON plc to Present at Upcoming Investor Conferences	Feb. 26	BU
ICON plc Reports Full Year 2023 Results	Feb. 22	AQ
Icon PLC: Q4 Earnings Snapshot	Feb. 21	AQ
ICON Reports Fourth Quarter and Full Year 2023 Results	Feb. 21	BU
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call	Jan. 31	AQ
ICON plc Schedules Q4 and Full Year 2023 Earnings Conference Call	Jan. 31	AQ
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call	Jan. 30	BU
New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment	Jan. 24	BU
ICON Issues Financial Guidance for Full Year 2024	Jan. 09	BU
Biotech companies to increase R&D spend but highlight complexity of clinical trials, ICON	Jan. 09	AQ
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON	Jan. 08	BU
ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 04	BU

No results for this search